Bartow R A, McMurray D N
Department of Medical Microbiology and Immunology, College of Medicine, Texas A&M University Health Science Center, College Station 77843-1114, USA.
Tuber Lung Dis. 1997;78(3-4):185-93. doi: 10.1016/s0962-8479(97)90025-3.
Immunity to mycobacterial stress protein antigens was studied in response to vaccination and/or virulent infection.
Guinea pigs, either vaccinated with Mycobacterium bovis bacille Calmette-Guérin (BCG), infected by the pulmonary route with virulent M. tuberculosis, or vaccinated then infected, were studied for the development of cellular and humoral immunity to two recombinant mycobacterial stress proteins, hsp 65 and hsp 70.
Recombinant hsp 70 stimulated good proliferation in blood lymphocytes and, to a lesser extent, spleen and bronchotracheal lymph node lymphocytes from BCG-vaccinated guinea pigs. The proliferative responses to hsp 70 were diminished in both the spleen and lymph node cells following subsequent pulmonary challenge alone, but were boosted significantly by prior vaccination. Recombinant hsp 65 was much less active at inducing the proliferation of spleen and lymph node cells, with lowest responses observed in blood lymphocytes occurring in the cells from BCG-vaccinated, aerosol-challenged guinea pigs. Using a semi-quantitative dot blot procedure, serum antibodies to both hsp 65 and hsp 70 developed gradually following BCG vaccination, with all guinea pigs studied exhibiting significant seroreactivity after 15 weeks post-vaccination. In guinea pigs exposed to virulent M. tuberculosis by aerosol, serologic reactivity to hsp 70 was consistently stronger 6 weeks post-challenge in both vaccinated and non-vaccinated guinea pigs. In fact, 6 weeks following pulmonary exposure to M. tuberculosis in previously naive guinea pigs, 3 out of 6 animals had no detectable serum antibodies to hsp 65. Somewhat surprisingly, antibody levels to both hsp 65 and hsp 70 were only slightly increased by prior BCG vaccination in guinea pigs exposed to virulent M. tuberculosis by the respiratory route.
These results demonstrate that both hsp 65 and hsp 70 stimulate detectable humoral and cell-mediated immunity in guinea pigs vaccinated and/or infected under highly relevant conditions. There is little evidence that vaccination with BCG primes the guinea pig to make an anamnestic response to hsp 65 following virulent pulmonary challenge. The precise contribution of immunity to mycobacterial stress proteins to the pathogenesis of tuberculosis in this model remains to be elucidated.
研究针对结核分枝杆菌应激蛋白抗原的免疫反应,以应对疫苗接种和/或强毒感染。
对豚鼠进行研究,这些豚鼠要么接种卡介苗(BCG),要么经肺部途径感染强毒结核分枝杆菌,或者先接种疫苗再进行感染,观察其对两种重组结核分枝杆菌应激蛋白hsp 65和hsp 70的细胞免疫和体液免疫的发展情况。
重组hsp 70能显著刺激接种BCG的豚鼠血液淋巴细胞增殖,对脾脏和气管支气管淋巴结淋巴细胞的刺激作用稍弱。仅在后续肺部感染后,脾脏和淋巴结细胞对hsp 70的增殖反应减弱,但预先接种疫苗可显著增强这种反应。重组hsp 65诱导脾脏和淋巴结细胞增殖的活性要低得多,在接种BCG并经气溶胶攻击的豚鼠的血液淋巴细胞中观察到的反应最低。采用半定量斑点印迹法,接种BCG后,针对hsp 65和hsp 70的血清抗体逐渐产生,所有研究的豚鼠在接种后15周均表现出显著的血清反应性。在经气溶胶暴露于强毒结核分枝杆菌的豚鼠中,接种和未接种疫苗的豚鼠在攻击后6周对hsp 70的血清学反应始终更强。事实上,在先前未接触过结核分枝杆菌的豚鼠经肺部暴露于结核分枝杆菌6周后,6只动物中有3只检测不到针对hsp 65的血清抗体。有点令人惊讶的是,在经呼吸道暴露于强毒结核分枝杆菌的豚鼠中,预先接种BCG仅使针对hsp 65和hsp 70的抗体水平略有增加。
这些结果表明,在高度相关的条件下,接种疫苗和/或感染的豚鼠中,hsp 65和hsp 70均能刺激可检测到的体液免疫和细胞介导免疫。几乎没有证据表明接种BCG能使豚鼠在受到强毒肺部攻击后对hsp 65产生回忆反应。在该模型中,针对结核分枝杆菌应激蛋白的免疫对结核病发病机制的确切贡献仍有待阐明。